(Q40707546)

22 September 2017

Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine (English)

1 reference

22 September 2017

1 reference

Olivier Van Der Meeren

series ordinal

1

1 reference

22 September 2017

Ulrich Behre

series ordinal

2

1 reference

22 September 2017

Priya Crasta

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

16 April 2016

1 reference

22 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

22 September 2017

34

1 reference

22 September 2017

24

1 reference

22 September 2017

2745-2749

1 reference

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

The global impact of vaccination against hepatitis B: a historical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Hepatitis B vaccine -- do we need boosters?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Are booster immunisations needed for lifelong hepatitis B immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Long-term protection against carriage of hepatitis B virus after infant vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

A review of the long-term protection after hepatitis A and B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

Hepatitis B vaccines: WHO position paper--recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.013

10.1016/J.VACCINE.2016.04.013

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference